Skip to main content

Table 4 Phenotypical analysis of α -type-1 DCs after a 7-day culture

From: α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Markers

Frequency (%)*

Markers

Frequency (%)

Markers

Frequency (%)

CD1a

16.3±13.2

CD80

92.4±15.5

CMRF44

3.7±2.4

CD11c

99.3±0.6

CD83

44.7±19.5

CMRF56

37.1±11.2

CD33

7.0±3.8

CD86

99.6±0.3

E-cadherin

13.1±7.4

CD40

95.9±5.1

CD205

73.9±12.1

CCR7

6.0±1.9

CD54

99.3±1.2

CD207

92.3±11.6

HLA-class I

99.0±1.2

  1. * Each value represents the frequency of marker-positive cells in lineage-HLA-DR+ gated population.